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Abstract
Background: Shiga toxins 1 and 2 (Stx1 and Stx2) are bacteriophage-encoded proteins that have
been associated with hemorrhagic colitis, hemolytic uremic syndrome and other severe disease
conditions. Stx1 and Stx2 are genetically and immunologically distinct but share the same
compound toxin structure, method of entry and enzymatic function.
Results: Phylogenetic analysis was performed using Stx1 and Stx2 amino acid and nucleotide
sequences from 41 strains of Escherichia coli, along with known stx sequences available from
GenBank. The analysis confirmed the Stx1 and Stx2 divergence, and showed that there is generally
more sequence variation among stx2 genes than stx1. The phylograms showed generally flat
topologies among our strains' stx1 and stx2 genes. In the stx2 gene, 39.5% of the amino acid sites
display very low nonsynonymous to synonymous substitution ratios.
Conclusion: The stx1 and stx2 genes used in this phylogenetic study show sequence conservation
with no significant divergence with respect to place or time. These data could indicate that Shiga
toxins are experiencing purifying selection.
Background
Shiga toxin was discovered in Shigella dysenteriae serotype
1 by Kiyoshi Shiga in 1898 [1]. The cytotoxic effects of
Escherichia coli-produced Shiga toxin on Vero cells were
first described 29 years ago [2]. A few years later, the toxin
was closely associated with hemorrhagic colitis, hemolytic
uremic syndrome (HUS) and other severe disease condi-
tions [3,4]. Shiga toxin producing E. coli have been impli-
cated in food borne, waterborne and airborne outbreaks
in studies all over the world [5-7]. Much of the focus of
identification and characterization of Shiga toxin has
been on E. coli O157:H7 strains, even though many cases
of Shiga toxin associated disease were caused by other
serotypes of E. coli [8]. The toxin has also been observed
in other bacterial genera, including Citrobacter, Entero-
bacter and Acinetobacter [9-11].
Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2) are encoded
on a lambdoid bacteriophage. Stx1 is genetically and
immunologically distinct from Stx2, showing 55–60%
genetic and amino acid identity [12]. Stx1 is very similar
to the Shiga toxin (Stx) found in Shigella dysenteriae type 1
[13]. Several variants of Stx1 (Stx1c and Stx1d) and Stx2
(Stx2c, Stx2d, Stx2e, Stx2f, and Sxt2g) have been described
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up of one 32 kDa A subunit and five identical 7.7 kDa B
subunits[18,19]. The B subunits form a pentameric hol-
low ring that encircles the carboxyl end of the A amino
acid chain. The B subunits of Stx1, and most Stx2 type
toxin molecules bind to specific glycosphingolipid glo-
botriaosylceramide (Gb3) receptors in eukaryotic cell
membranes. Stx2e B subunits preferentially bind to glo-
botetraosylceramide (Gb4) [20], which allows the toxin
to target different cell types. Once bound, receptor medi-
ated endocytosis produces toxin-containing vesicles that
travel through the Golgi apparatus and endoplasmic retic-
ulum. The A subunit is then proteolytically cleaved into
A1 (27.5 kDa) and A2 (4.5 kDa), but A1 and A2 remain
covalently connected through a disulfide bond between
two cysteine residues. When the cysteines are reduced, the
catalytically active A1 enzyme cleaves a specific adenine
from the 28S rRNA of the 60S ribosomal subunit [21].
Without this adenine, the GTP/elongation factor Tu/
amino acyl-tRNA complex is unable to associate properly
with the ribosome. Amino acid chain elongation is
stopped, usually resulting in cell death.
Shiga toxin was shown to have the same N-glycosidase
depurinating enzymatic function and active site confor-
mation found in another ribosomal inhibiting protein
(RIP), ricin [22,23]. Comparison of the crystal structures
of Stx from Shigella dysenteriae [19] and Stx2 from E. coli
[24] showed that the active sites were similar to that of
ricin. Both ricin and Shiga toxin are considered type II
RIPs because of the lectin property of the B subunit that
allows the enzymatic A subunit to be internalized for
access to the ribosome. Abrin, modeccin, volkensin and
viscumin are examples of other RIPs that use the same
method of entry and mechanism of action [25-28].
Despite their similarities, Stx1 and Stx2 produce different
degrees and types of tissue damage. Enterohemorrhagic E.
coli that produce Stx2 are more likely to cause hemolytic
uremic syndrome than are Stx1 producers [29]. This could
be due to accessibility of the active site, differences in the
carboxyl end of the A subunit, or differences in binding
affinities of the B subunit pentamer to Gb3 [24].
Other studies have shown how different types of patho-
genic E. coli and Shigella have developed using multilocus
sequence typing (MLST) of several housekeeping genes
[30-32], genomic hybridization by microarray [33] and
comparative genomic sequencing by microarray [34].
Since Shiga toxin is encoded on a mobilizable bacteri-
ophage, we focused on the phylogenetic diversity of the
gene rather that the bacterium that happens to carry it. In
this study we compared Shiga toxin gene nucleotide and
amino acid sequences from twenty nine reference strains
from the National Food Safety & Toxicology Center at
Michigan State University and twelve clinical isolates
from the Idaho Department of Health that contained one
or both Stx genes. The E. coli strains used are both tempo-
rally and spatially distinct (Table 1). Included in the anal-
ysis were unique Shiga gene sequences that were available
from Genbank. We confirmed that Stx2 shows more
sequence variation than Stx1 among our reference and
clinical isolates. We also showed that our isolates' stx1 and
stx2 genes each respectively showed little divergence and
may display purifying selection.
Results and Discussion
Similarity of Shiga Toxin 1 A and B subunit genes
The Shiga Toxin 1 A and B subunit genes showed very lit-
tle difference in amino acid sequence (Figure 1). There
were only four amino acid differences among the stx1
genes in the entire alignment. The change from threonine
to serine at A67 in strains H19, BCL17 and I6650 would
predictably have little effect on the enzymatic activity of
the A subunit. The B354 change from threonine to serine
in 88–1509 and the B357 change from valine to alanine
in H19 are also unlikely to change the binding function of
the B subunit.
The phylogenetic trees made from the nucleotide
sequences (Figure 2) and the amino acid sequences (Fig-
ure 3) were topologically the same with very short branch
lengths. Bootstrap replicates in both trees supported the
H19/BCL17/I6650 clade and the Shigella dysenteriae/
88–1509 clade. The short branch lengths and relatively
low bootstrap values can be directly attributed to the low
number of informative characters in the analysis.
Similarity of Shiga Toxin 2 A and B subunit genes
The Shiga toxin 2 A and B subunit sequences showed
much more sequence diversity than did the Stx1 group.
None of the putative substitutions replaced key residues
used in the active site [24] or either of the cysteines that
form the disulfide bridge between A1 and A2. There were
56 total amino acid differences from EDL933 Stx2 in this
study's sequences, 28 in the A subunit and 28 in the B sub-
unit. Twenty-five of these changes occurred in I7606 Stx2.
The number of positions in each subunit that were
affected was 17 for the A subunit and 15 for the B subunit.
The Stx2 alignment (Figure 4) shows all of the amino acid
differences among this study's sequences, along with
Stx2d1, Stx2d2, Stx2e, Stx2f, Stx2g and Citrobacter freundii
Stx2 sequences from GenBank.
Strains E32511 and B2F1 have each been shown to con-
tain two copies of the stx2 gene [35,36]. E32511 carries
one stx2 gene that is almost identical to the EDL933
sequence and a second that differs by 15 nucleotides.
Three of these nucleotide differences result in three amino
acid changes in the B subunit only. The stx2 amplifiedPage 2 of 12
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M59432 with no equivocal peaks in the chromatogram.
B2F1 carries the stx2d1 and stx2d2 genes represented by
the accessions AF479828 and AF479829, respectively.
These sequences differ from EDL933 stx2 by 10 nucle-
otides with one amino acid change. The sequencing reac-
tion chromatogram from our stx2 amplicon of the B2F1
strain showed nucleotide differences between both stx2d1
and stx2d2 with no ambiguities. These differences resulted
in three amino acid changes along the sequence. In both
E32511 and B2F1, the few sequence differences did not
affect our analysis. However, until further analysis of our
E32511 and B2F1 strains is complete to determine
whether they contain one or two stx2 genes, our sequences
EF441603 and EF441620 should be held in question.
The ratio non-synonymous (dN) to synonymous (dS) sub-
stitutions was used to estimate whether positive or purify-
ing selection had occurred at each amino acid site. A
nonsynonymous:synonymous (dN:dS) ratio of greater
than one indicates positive selection at that amino acid
site whereas a dN:dS ratio of less than one shows purifying
selection. Forty percent of the amino acid sites in the full
alignment showed purifying selection using the Selecton
Table 1: E. coli reference strains used in this study. Information for the strains obtained from the National Food Safety & Toxicology 
Center at Michigan State University was taken directly from their web site.
Michigan State 
Name






O antigen H antigen Host Location Date
EDL933 stx1 157 7 Food Michigan 1982
stx2
93–111 E12 stx1 EF441572 157 7 Human Washington 1993
stx2 EF441599
OK-1 E13 stx1 EF441573 157 7 Human Japan 1996
stx2 EF441600
86-24 E14 stx2 EF441601 157 7 Human Washington 1986
2886-75 E15 stx1 EF441574 157 7 Human California 1975
493/89 E16 stx2 EF441602 157 - Human Germany 1989
E32511 E17 stx2 EF441603 157 - Human No Data 1985
G5101 E18 stx1 EF441575 157 7 Human Washington 1995
stx2 EF441604
5905 E19 stx2 EF441605 55 7 Food No data 1994
DEC8B E22 stx1 EF441576 111 8 Human Idaho 1986
stx2 EF441606
3007-85 E23 stx1 EF441577 111 - Human Nebraska 1985
stx2 EF441607
TB226A E24 stx2 EF441608 111 - Human Washington 1991
928/91 E25 stx1 EF441578 111 - Human Germany 1991
stx2 EF441609
412/55 E26 stx1 EF441579 111 No data Human Germany 1955
DEC8C E27 stx1 EF441580 111 - Calf Scotland No data
C412 E28 stx1 EF441581 111 No data Calf S. Dakota 1986
H19 E29 stx1 EF441582 26 11 Human Canada 1977
DEC10B E210 stx1 EF441583 26 11 Human Australia 1986
TB285C E213 stx1 EF441584 26 - Human Washington 1991
BCL19 E216 stx1 EF441585 No data - Cow California No data
DEC10J E217 stx1 EF441586 70 11 Human Canada 1988
ED-31 E218 stx1 EF441587 111 - Human Italy No data
stx2 EF441610
CL-3 S1 stx2 EF441618 113 21 Human Canada 1980
G5506 S3 stx2 EF441619 104 21 Human Montana 1994
B2F1 S4 stx2 EF441620 91 21 Human Canada 1985
TB154A S7 stx1 EF441595 103 6 Human Washington 1991
88–1509 S8 stx1 EF441596 15 27 Human Canada 1988
stx2 EF441621
M2113 S10 stx1 EF441597 156 21 Cow Germany No data
BCL17 S11 stx1 EF441598 5 No data Cow California No data
90–1787 S12 stx2 EF441622 X03 - Cow Canada No data
1These names used only in the alignments.Page 3 of 12
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Stx1 A and B Subunit Amino Acid AlignmentFigure 1
Stx1 A and B Subunit Amino Acid Alignment. Sequences that are identical are on the same line and are pipe-delimited.
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BMC Microbiology 2007, 7:109 http://www.biomedcentral.com/1471-2180/7/109program [37]. The Stx2 A and B subunits showed 37.3%
and 44.9%, respectively, of their amino acid sites were
well conserved. (Figure 5)
The nucleotide phylogenetic tree (Figure 6) and the
amino acid phylogenetic tree (Figure 7) showed almost
the same topology with short branch lengths for our
strains. The obvious dissimilarity of Stx2e, Stx2f and Stx2g
is striking in both the alignment and phylogenetic trees
and is well supported by the high bootstrap values. Idaho
strain I7606 had the most divergent sequence among the
strains obtained from the Idaho State Health Department
and is most closely related to Stx2d A subunit [38]. The
lower bootstrap values in the figures are characteristic of
highly similar sequences in the branches. Interestingly,
the C. freundii Stx2 grouped with the Stx2d group of
elastase activated Shiga toxins [39].
Conclusion
This investigation into the phylogenetic relationships
among Shiga toxins confirmed that the two major groups,
Stx1 and Stx2, are easily differentiated by both their
amino acid and nucleotide sequences. The phylogram in
Figure 8 shows stx1 and stx2 forming two distinct clades
with stx2f branching off significantly from both. The stx1
group displayed an almost flat phylogeny whereas the stx2
group has much more sequence diversity. Stx2d, Stx2e
and Stx2g all show at least 91% similarity to the EDL933
stx2 gene. The Stx2f amino acid and nucleotide sequences
are only 72.5 and 70.4 percent similar to EDL933 Stx2
sequences, respectively, making it the most divergent Stx2
found to date. The greater diversity of Stx2 sequences
could be the result of sampling bias. Since the majority of
the gene sequences came from human outbreak patho-
gens and because Stx2 is associated with more severe dis-
ease, this could have an effect on what strains are
Stx1 Distance Amino Acid Phylogenetic Tree (unrooted)Figure 3
Stx1 Distance Amino Acid Phylogenetic Tree 
(unrooted). Bootstrap values over 50% are displayed. Pipe-
delimited strain names indicate identical sequences. Dates 
and locations of the isolates are shown if available. The hori-
zontal bar shows 0.001 amino acid substitutions per site.
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stx1 Maximum Likelihood Nucleotide Phylogenetic Tree (unrooted)Figure 2
stx1 Maximum Likelihood Nucleotide Phylogenetic 
Tree (unrooted). Bootstrap values over 50% are displayed. 
Pipe-delimited strain names indicate identical sequences. 
Dates and locations of the isolates are shown if available. The 
horizontal bar shows 0.001 nucleotide substitutions per site.
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BMC Microbiology 2007, 7:109 http://www.biomedcentral.com/1471-2180/7/109recovered. Despite the fact that diarrheal illness is a lead-
ing causes of death worldwide [40], most sources provid-
ing isolates used in this study are located in areas with well
established public health systems. This source location
could also introduce bias into the isolates investigated.
The significance of compiling these sequences became
clear when both the Stx1 tree and Stx2 tree showed gener-
ally flat topologies. Our further analysis of the nucleotide
sequences for Stx2 A and B subunits showed that a large
proportion of the amino acid sites had undergone purify-
ing selection. Our hypothesis when undertaking this
Stx2 A and B Subunit Amino Acid AlignmentFigure 4
Stx2 A and B Subunit Amino Acid Alignment. Sequences that are identical are on the same line and are pipe-delimited.
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EDL933S2  MKCILFKWVLCLLLGFSSVSYSREFTIDFSTQQSYVSSLNSIRTEISTPLEHISQGTTSVSVI-NHTPPGSYFAVDIRGLDVYQARFDHLRLIIEQNNLYVAGFVNTATNTFYRFSDFTHISVPGVTTVSMTTDSSYTTL
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E13Stx2   ...............................................................-............................................................................
E17Stx2   ...............................................................-............................................................................
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E22Stx2   ...............................................................-............................................................................
E25Stx2   ...............................................................-............................................................................
E218Stx2  ...............................................................-............................................................................
I6581S2   ...............................................................-............................................................................
I6896S2   ...............................................................-............................................................................
I7606S2   .........................M.....................................-............................................................................
I8257S2   ...............................................................-............................................................................
S1Stx2    ...............................................................-............................................................................
S3Stx2    ...............................................................-............................................................................
S4Stx2    ...............................................................-............................................................................
S8Stx2    ...............................................................-............................................................................
S12 Stx2  ...............................................................-............................................................................
Stx2e     .....L..I.............Q.....................A...........A......-........IS.G........E..........R...........T..........A...L.....I...........
Stx2f     .RH..L.L..FFCVCL..A..AD...V...S.K...D......SA.....GN....GV.....-..V.G.N.ISLNV....P.SE..N.....M.R........I..E..........S.....D.I..........SS.
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E19Stx2   .....................................................................-......................................................................
E22Stx2   .....................................................................-......................................................................
E25Stx2   .....................................................................-......................................................................
E218Stx2  .....................................................................-......................................................................
I6581S2   .....................................................................-......................................................................
I6896S2   .....................................................................-......................................................................
I7606S2   .........................................................E...........-.......EE........T.......F...G.......................................I
I8257S2   .....................................................................-......................................................................
S1Stx2    .....................................................................-......................................................................
S3Stx2    .....................................................................-......................................................................
S4Stx2    .....................................................................-......................................................................
S8Stx2    .....................................................................-......................................................................
S12 Stx2  .....................................................................-......................................................................
Stx2e     ..............................................................L......-.......E.....................A........................................
Stx2f     ..I.D...T....G.....G...D....R.RS...AS...M......I...........G..P....AS-.L....AQ.....................E...I......SL.....S........ST.SY...S.SQKQ
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EDL933S2  QPECQITGDRPVIKINNTLWESNTAAAFLNRKSQFLYTTGKMKKMFMAVLFALASVNAMAADCAKGKIEFSKYNEDDTFTVKVDGKEYWTSRWNLQPLLQSAQLTGMTVTIKSSTCESGSGFAEVQFNND
E12Stx2   .................................................................................................S................................
E13Stx2   ..................................................................................................................................
E17Stx2   .....................................................V.....................N.......A..............................................
E18Stx2   .....................................................V.....................N.......A........................................L.....
E19Stx2   ..................................S.....E............V.....................N.......A..................R...........................
E22Stx2   ..................................................................................................................................
E25Stx2   ..............................................................................................................L...................
E218Stx2  ..................................................................................................................................
I6581S2   ...................................................................................A..............................................
I6896S2   ..................................................................................................................................
I7606S2   .............R.................RAHS.N.S--...I.V.A...FV.....................N.......A......N......................N..A.............
I8257S2   ..................................................................................................................................
S1Stx2    .....................................................V.............................A..............................................
S3Stx2    ..................................S.....E............V.......................................................................H....
S4Stx2    ..................................S.....E............V............................................................................
S8Stx2    ..................................S.....E............V.....................N.......A..............................................
S12 Stx2  .....................................................V.........................................H..................................
Stx2e     .................K................P.....E.....I......V......................N......S.R....N....................I.N..S......Q.K..--
Stx2f     KT....V...AA..V..V...A..I..L....P.D.TEPNQ....II....G.F.A.S......V..................S.R....N....................I.N..S......Q.K..--
Stx2g     ......S...........................S.....E............V....................G.N.............N......................N................
CitrStx2  ..................................S.....E............V.....................N.......A..............................................
Stx2d2 ..................................S.....E............V.....................N.......A..............................................
Stx2d1 ..................................S.....E............V.....................N.......A..............................................Page 6 of 12
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BMC Microbiology 2007, 7:109 http://www.biomedcentral.com/1471-2180/7/109project was that Shiga toxin sequences from different
places and collected at different times would show diver-
gence. Our data analysis indicates that there is no signifi-
cant divergence among either the Stx1 or Stx2 gene
sequences based on collection time or location. The Stx1
phylogeny (Figure 2 and 3) shows that these genes do not
vary greatly and are perhaps undergoing purifying selec-
tive pressure. The Stx2 phylogeny (Figure 4 and 5) is also
generally flat among the strains we tested. This would
indicate that among our strains, both the Stx1 and Stx2
gene sequences are closely conserved. One reason for the
conservation of this sequence could be that intestinal
Shiga toxin producing E. coli in the bovine host are miti-
gating Bovine Leukemia Virus induced disease [41].
Another recent finding suggests that the Shiga toxin might
play a role in helping E. coli survive predation from bacte-
riovores outside of the cow [42]. Since many of our strains
can be related to illness produced from bovine feces, it is
possible that a Shiga toxin gene that is beneficial to the
bacterium that carries it has undergone purifying selection
to the benefit of both their bacterial and mammalian host.
Methods
Culture and Colony Isolation
Forty-one strains of Escherichia coli were used, including
29 outbreak reference strains provided by the National
Food Safety & Toxicology Center at Michigan State Uni-
versity, and twelve clinical isolates from patients reported
to the Idaho Department of Health. The characteristics
and sources of E. coli strains used are described in Table 1.
The specimens were received as 25% glycerol stocks on
wet ice. E. coli strains were grown at 37°C in Luria-Bertani
(LB) broth and isolated on LB agar.
DNA Extraction
After isolation on LB agar, each strain was grown in 11 ml
of LB broth for 18–24 hours at 37°C with shaking. All
DNA extractions were performed using the PureGene
DNA Isolation Kit (Gentra Systems, Minneapolis, MN).
To maximize the yield of DNA, the following modifica-
tions to the PureGene protocol were made: 1) The time for
cell lysis was increased to 10 minutes; 2) The DNA was
precipitated using 300 μl 100% Isopropanol (tubes were
inverted 50 times, incubated at -20°C for 1 hour and then
centrifuged for 5 minutes at 13–16,000 × g); 3) DNA was
dissolved in 100 μl sterile filtered 10 mM Tris, pH 8.3.
Color Coded Selecton Results for stx2 SequencesFigu e 5
Color Coded Selecton Results for stx2 Sequences. Nonsynonymous:synonymous (dN:dS) ratios using the output from 
the Selecton program. Shades of yellow (1 and 2) indicate a dN:dS ratio of > 1 or positive selection. Any shade of bordeaux 
(4–7) indicates a dN:dS ratio of < 1 or purifying selection.Page 7 of 12
(page number not for citation purposes)
BMC Microbiology 2007, 7:109 http://www.biomedcentral.com/1471-2180/7/109Amplification of Stx genes
Primer sequences targeting specific stx1 and stx2 genes are
listed in Table 2, along with PCR conditions used. The stx1
primers amplified 1178 bp of the 1227 bp sequence. The
stx2 primers amplified the entire 1241 bp sequence. PCR
master mix was made to final concentration of 1 × Ther-
moPol Reaction Buffer (New England BioLabs, Beverly,
MA), 500 μM dNTP's (New England BioLabs), 0.02 units/
μl Vent exo(-) polymerase (New England BioLabs), and 1
μM of each of the stx1 primers or stx2 primers. Five micro-
liters of each amplification reaction was analyzed by 1%
agarose gel electrophoresis. All gels were run at 80–90 V
for 90 minutes in 1 × TAE buffer. Both gel and buffer con-
tained 0.5 mg/ml ethidium bromide.
Purification and Sequencing of Amplification Products
Amplicons were extracted from agarose gels using the
QIAquick Gel Extraction Kit (Qiagen, Valencia, CA)
according to the manufacturer's specifications. The ampli-
cons were further purified for sequencing using Millipore
Montage PCR filters (Billerica, MA). All sequencing was
performed by the Idaho State University Molecular
Research Core Facility using primers listed in Table 2.
Accession numbers for nucleotide sequences submitted to
GenBank are shown in Table 3.
Sequence Alignment and Phylogenetic Analysis
All amplicons were sequenced on both strands except the
first and last 30 bases that were sequenced in only one
direction in duplicate from internal primers. Raw
sequence alignment was performed using Vector NTI 9
(InforMax, Invitrogen, Carlsbad, CA). Reference
sequences for Shiga toxins used in the analysis were
obtained from GenBank and are indicated in the phyloge-
netic tree by their accession numbers. Consensus
sequences were entered into BioEdit 7.0.5.2 [43], aligned
using ClustalW and then manually trimmed so that the
Stx2 Distance Amino Acid Phylogenetic Tree (unrooted)Figure 7
Stx2 Distance Amino Acid Phylogenetic Tree 
(unrooted). Bootstrap values over 50% are displayed. Pipe-
delimited strain names indicate identical sequences. Dates 
and locations of the isolates are shown if available. The hori-
zontal bar shows 0.1 amino acid substitutions per site.
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BMC Microbiology 2007, 7:109 http://www.biomedcentral.com/1471-2180/7/109nucleotide sequence accurately reflected the amino acid
sequence. Amino acid sequence phylogenetic trees were
created by distance analysis of the alignment using PAUP
4.0 Beta 10 [44]. Nucleotide phylogenetic trees were gen-
erated by maximum likelihood analysis of the alignment
using PAUP 4.0 Beta 10 [44]. The Hasegawa-Kishino-
Yano or HKY (stx1) and HKY with gamma likelihood
models (stx2) were chosen after the data were analyzed
using ModelTest [45] in PAUP. Construction of the nucle-
otide trees was done using the neighbor joining method
with 1000 bootstrap replicates. The Selecton program [37]
was used to determine the ratio of non-synonymous to
synonymous substitutions. The top two purifying selec-
tion categories of 6 and 7 on the selection scale were used
to calculate percentage of amino acids that were undergo-
ing purifying selection. The maximum likelihood nucle-
otide phylogenetic tree produced above was inputted and
the M8 evolutionary model [46] was used with EDL933
Unrooted Maximum Likelihood Nucleotide Phylogenetic Tree of all Shiga Toxin SequencesFigure 8
Unrooted Maximum Likelihood Nucleotide Phylogenetic Tree of all Shiga Toxin Sequences. The horizontal bar 
shows 0.1 nucleotide substitutions per site.
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Table 3: Primer sequences
Primer Name Nucleotide Sequence 5'-3' Target PCR Conditionsa
PCR Primers Denature Anneal Extension
BGR1U TCAACGAAAAATAACTTCGCTGAATCCC Stx1 Base 1–28 95°C, 61°C, 72°C,
BGR1D CAGTTAATGTGGTTGCGAAGGAATTTACC Stx1 Base (1150–1178) 60 sec 60 sec 240 sec
BGR2U ATGAAGTGTATATTATTTAAATGGGTACTGTG Stx2 Base 1–32 95°C, 61°C, 72°C,
BGR2D TCAGTCATTATTAAACTGCACTTCAG Stx2 Base (1201–1226) 60 sec 60 sec 240 sec
Sequencing Primers Target
Stx1SeqF TGTAACCGCTGTTGTACCTGG Stx1 Base (367–387)
Stx1SeqR TTAATACTGAATTGTCATCATCATGC Stx1 Base 778–803
Stx2SeqF TTGCATTAGCTTCTGTTAATGCA Stx2 Base 1000–1022
Stx2SeqR CATTCCGGAACGTTCCAG Stx2 Base (433–450)
a PCR was performed for 30 cycles followed by a final extension step of 10 min at 72°C.
Table 2: Idaho E. coli strains used in this study. Information on the Idaho strains was obtained from the Idaho Department of Health.




O antigen H antigen Host Location Date
I5365 stx1 EF441588 26 11 Human Idaho 2004
I5518 stx2 EF441611 121 19 Human Idaho 2004
I5533 stx1 EF441589 157 - Human Idaho 2004
stx2 EF441612
I6581 stx2 EF441613 157 7 Human Idaho 2004
I6650 stx1 EF441590 No data No data Human Idaho 2004
I6896 stx2 EF441614 145 - Human Idaho 2004
I6940 stx1 EF441591 145 - Human Idaho 2004
I7004 stx2 EF441615 157 7 Human Idaho 2004
I7606 stx2 EF441616 146 21 Human Idaho 2004
I8257 stx1 EF441592 157 7 Human Idaho 2004
stx2 EF441617
I8361 stx1 EF441593 111 - Human Idaho 2004
I8419 stx1 EF441594 103 25 Human Idaho 2004
BMC Microbiology 2007, 7:109 http://www.biomedcentral.com/1471-2180/7/109stx2 as the query sequence. Other evolutionary models
available (M8a, M7, M5, MEC) produced results that were
not significantly different. (data not shown) The full table
of non-synonymous to synonymous ratios for stx2
sequences is available in additional file 1.
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